NIH Clinical Research Studies

Protocol Number: 07-M-0036

Active Accrual, Protocols Recruiting New Patients

Title:
PET Imaging of Brain Amyloid Using [11C]MeS-IMPY
Number:
07-M-0036
Summary:
Alzheimer's disease is associated with accumulation in the brain of a protein called amyloid. The purpose of this study is to test the ability of a research drug to measure amyloid in brain using positron emission tomography (PET) and a research drug called [11C]MeS-IMPY.
Sponsoring Institute:
National Institute of Mental Health (NIMH)
Recruitment Detail
Type: Participants currently recruited/enrolled
Gender: Male & Female
Referral Letter Required: No
Population Exclusion(s): Children

Eligibility Criteria:
INCLUSION CRITERIA:

Healthy control subjects aged 18-90 years and AD patients aged 50-90, with history/physical exam, ECG, and laboratory tests.

Informed Consent.

AD Patients: Mini-Mental State Examination (score greater than or equal to 10).

AD Patients: Meet NINCDS-ADRDA criteria for probable AD.

EXCLUSION CRITERIA:

1. Current or prior history of any alcohol or drug abuse.

2. Severe systemic disease based on history and physical exam.

3. Positive result on urine screen for illicit drugs.

4. Laboratory tests with clinically significant abnormalities.

5. Prior participation in other research protocols or clinical care in the last year such that radiation exposure would exceed the annual limits.

6. Pregnancy or breast feeding.

7. Claustrophobia.

8. Presence of ferromagnetic metal in the body or heart pacemaker.

9. History of brain disease other than Alzheimer's disease.

10. Unable to lay on one's back for the PET/MRI scan.

Special Instructions:
Currently Not Provided
Keywords:
Alzheimer's Disease
Positron Emission Tomography
Brain
Neurochemistry
Beta-Amyloid Plaques
PET
MeS-IMPY
Recruitment Keyword(s):
Alzheimer Disease
AD
Dementia
Healthy Volunteer
HV
Condition(s):
Alzheimer's Disease
Healthy
Investigational Drug(s):
[11C]MeS-IMPY
Investigational Device(s):
None
Intervention(s):
Drug: [11C]MeS-IMPY
Supporting Site:
National Institute of Mental Health

Contact(s):
Patient Recruitment and Public Liaison Office
Building 61
10 Cloister Court
Bethesda, Maryland 20892-4754
Toll Free: 1-800-411-1222
TTY: 301-594-9774 (local),1-866-411-1010 (toll free)
Fax: 301-480-9793

Electronic Mail:prpl@mail.cc.nih.gov

Citation(s):
Agdeppa ED, Kepe V, Liu J, Flores-Torres S, Satyamurthy N, Petric A, Cole GM, Small GW, Huang SC, Barrio JR. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J Neurosci. 2001 Dec 15;21(24):RC189.

Burger C, Buck A. Requirements and implementation of a flexible kinetic modeling tool. J Nucl Med. 1997 Nov;38(11):1818-23.

Ichise M, Toyama H, Innis RB, Carson RE. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab. 2002 Oct;22(10):1271-81.

Active Accrual, Protocols Recruiting New Patients

If you have:


Command Menu Bar

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home


Clinical Center LogoNational Institutes of Health Clinical Center Bethesda, Maryland 20892. Last update: 09/17/2008
Search The Studies Help Questions